Recruiting Pancreatic Cancer Studies in Harrison
A Study of NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC)
The researchers are doing this study to find out whether using the chemotherapy regimen NALIRIFOX in combination with ablative dose radiation therapy (AD-XRT) and the standard chemotherapy drug capeci...
A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer
The purpose of this study is to find out how effective and safe glipizide is for lowering blood sugar in people with pancreatic cancer....
About Pancreatic Cancer Clinical Trials in Harrison
Pancreatic cancer begins in the tissues of the pancreas and is often diagnosed at an advanced stage. It is one of the most challenging cancers to treat. Clinical trials are actively investigating new approaches including immunotherapy and combination regimens.
There are currently 2 pancreatic cancer clinical trials recruiting participants in Harrison, NY. These studies are seeking a combined 100 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pancreatic Cancer Clinical Trials in Harrison — FAQ
Are there pancreatic cancer clinical trials in Harrison?
Yes, there are 2 pancreatic cancer clinical trials currently recruiting in Harrison, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Harrison?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Harrison research site will contact you about next steps.
Are clinical trials in Harrison free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Harrison studies also compensate for your time and travel.
What pancreatic cancer treatments are being tested?
The 2 active trials in Harrison are testing new therapies including novel drugs, biologics, and treatment approaches for pancreatic cancer.
Data updated March 2, 2026 from ClinicalTrials.gov